dipyridamole has been researched along with Cognition Disorders in 5 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hydrogen sulfide is an environmental toxicant and gaseous neurotransmitter." | 1.39 | Presumed hydrogen sulfide-mediated neurotoxicity after streptococcus anginosus group meningitis. ( Landisch, R; Prah, M; Quirk, B; Schmainda, K; Verma, S; Whelan, HT; Willoughby, RE, 2013) |
| "Stroke is highly prevalent in long-term care." | 1.31 | Clinical correlates and drug treatment of residents with stroke in long-term care. ( Lapane, KL; Quilliam, BJ, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Douiri, A | 1 |
| McKevitt, C | 1 |
| Emmett, ES | 1 |
| Rudd, AG | 1 |
| Wolfe, CD | 1 |
| Bortolotto, JW | 1 |
| Melo, GM | 1 |
| Cognato, Gde P | 1 |
| Vianna, MR | 1 |
| Bonan, CD | 1 |
| Acelajado, MC | 1 |
| Oparil, S | 1 |
| Verma, S | 1 |
| Landisch, R | 1 |
| Quirk, B | 1 |
| Schmainda, K | 1 |
| Prah, M | 1 |
| Whelan, HT | 1 |
| Willoughby, RE | 1 |
| Quilliam, BJ | 1 |
| Lapane, KL | 1 |
5 other studies available for dipyridamole and Cognition Disorders
| Article | Year |
|---|---|
Long-term effects of secondary prevention on cognitive function in stroke patients.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Aspirin; Cognition Disorders; Dipyridamole; Female | 2013 |
Modulation of adenosine signaling prevents scopolamine-induced cognitive impairment in zebrafish.
Topics: Adenine; Adenosine; Adenosine Deaminase Inhibitors; Animals; Avoidance Learning; Cognition Disorders | 2015 |
Antiplatelet therapy for transient ischemic attack.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Brain Ischemia; Clopidogrel; Cognition Disorders; | 2012 |
Presumed hydrogen sulfide-mediated neurotoxicity after streptococcus anginosus group meningitis.
Topics: Brain; Child, Preschool; Cognition Disorders; Dipyridamole; Humans; Hydrogen Sulfide; Hyperbaric Oxy | 2013 |
Clinical correlates and drug treatment of residents with stroke in long-term care.
Topics: Aged; Aged, 80 and over; Aspirin; Cognition Disorders; Comorbidity; Cross-Sectional Studies; Databas | 2001 |